Viewing data from:

ACARBOSE

ANDA

ACARBOSE | A090912 | STRIDES PHARMA GLOBAL PTE LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.2224

per ea

Lowest NADAC/Unit

$0.1531

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64380076006ACARBOSE 100 MG TABLET	$0.2224	EA	Generic	—	2026-06-17
64380075906ACARBOSE 50 MG TABLET	$0.1646	EA	Generic	—	2026-06-17
64380075806ACARBOSE 25 MG TABLET	$0.1531	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

BAYER AGACARBOSE

DMF 85391990

ZHEJIANG HISUN PHARMACEUTICAL CO LTDACARBOSE USP

DMF 190692005

CKD BIO CORPACARBOSE, NON-STERILE BULK DRUG SUBSTANCE

DMF 207592007

HEBEI HUARONG PHARMACEUTICAL CO LTDACARBOSE

DMF 252072011

LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTDACARBOSE

DMF 351882020

CSPC SHENGXUE GLUCOSE CO LTDACARBOSE

DMF 356032021

HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL JIANGDONG CO LTDACARBOSE USP

DMF 371452022

HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDInactiveACARBOSE

DMF 181382005

LIVZON NEW NORTH RIVER PHARMACEUTICAL CO LTDInactiveACARBOSE

DMF 232792009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 27, 2011

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 27, 2011

#003 — 100MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 27, 2011